Table 3. HLC-080 and Sorfenib inhibits p-c-Raf (Ser259) activities in vitro.
| Compound | EC50 (µM) |
| HT-29 | |
| HLC-080 | 0.352±0.034 |
| Sorafenib | 0.957±0.039 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.